Save
Recognizing Excellence in Peer Review
ISTH Academy, Faculty / Presenter(s), 286318
The risk of arterial thromboembolic events after cancer diagnosis
ISTH Academy, Babak B. Navi, 286319
Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects
ISTH Academy, Christian Gachet, 286320
Hemostatic complications associated with ventricular assist devices
ISTH Academy, Thomas Deloughery, 286321
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability
ISTH Academy, Anne Angelillo- Scherrer, 286330
#WomenInMedicine: Progress in gender equity at Research and Practice in Thrombosis and Haemostasis
ISTH Academy, Mary Cushman, 286331
Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit
ISTH Academy, Erich De Paula, 286332
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
ISTH Academy, Pamela L. Lutsey, 286333
Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells
ISTH Academy, Ruben Bierings, 286334
Corrigendum
ISTH Academy, Faculty / Presenter(s), 286335
Blood platelets: Circulating mirrors of neurons?
ISTH Academy, Ilaria Canobbio, 286336
Post‐thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool
ISTH Academy, Maria Laura Avila, 286337
Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis
ISTH Academy, Maha Othman, 286345
Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
ISTH Academy, Oliver Königsbrügge, 286346
Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism
ISTH Academy, Robin Amanda Liang, 286243
Managing sepsis‐associated coagulopathy remains an enigma
ISTH Academy, Jecko Thachil, 286244
Hypothermia‐induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model
ISTH Academy, Hiroki Tanaka, 286245
Topical tranexamic acid inhibits fibrinolysis more effectively when formulated with self‐propelling particles
ISTH Academy, Amedeo Piazza, 286246
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
ISTH Academy, Sylvia Haas, 286247
Thromboembolism in major joint prosthetic surgery: False or fact
ISTH Academy, Ola E. Dahl, 286248
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey
ISTH Academy, Hannah Cohen, 286249
Definitions, adjudication, and reporting of pulmonary embolism–related death in clinical studies: A systematic review
ISTH Academy, Farrukh Awan, 286250
Platelet‐derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice
ISTH Academy, Matthew Neal, 286251
Trauma‐targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model
ISTH Academy, Anirban Sen Gupta, 286252
Heparin‐induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants
ISTH Academy, Uri Pollak, 286253
The role of a specialist bridging service. A New Zealand prospective study of 600 patients
ISTH Academy, Ruell Jackie, 286254
ISTH news and updates: Join the ISTH today
ISTH Academy, Faculty / Presenter(s), 286255
Toll‐like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis
ISTH Academy, Wei Chao, 286256
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability
ISTH Academy, Virginie Siguret-Depasse, 286257
Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome
ISTH Academy, Anetta Undas, 286258
The potential of serpins for future treatment for haemophilia
ISTH Academy, Josefin Ahnstrom, 286259
What The Neighbors Say
ISTH Academy, Faculty / Presenter(s), 286260
George J. Broze Jr., MD (3 August 1946–19 June 2019)
ISTH Academy, Faculty / Presenter(s), 286261
Engineering a protein Z‐dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment
ISTH Academy, Xin Huang, 286262
Issue Information
ISTH Academy, Faculty / Presenter(s), 286263
Tranexamic acid for trauma: Repackaged and redelivered
ISTH Academy, Keith Neeves, 286264
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH
ISTH Academy, Tzu-Fei Wang, 286265
Does the Villalta scale capture the essence of postthrombotic syndrome? A qualitative study of patient experience and expert opinion
ISTH Academy, Hilde Skuterud Wik, 286266
Risk assessment models: thromboprophylaxis & VTE recurrence
ISTH Academy, Lara Roberts and Sabine Eichinger, 273714
Inhibitors in hemophilia: Risk factors, biomarkers and other predictors
ISTH Academy, Samantha Gouw and Rolf Carl Ljung, 273713
A non‐circulating pool of factor XI associated with glycosaminoglycans in mice
ISTH Academy, stefan milewczyk, 286213
Physical proximity and functional cooperation of glycoprotein 130 and glycoprotein VI in platelet membrane lipid rafts
ISTH Academy, Isabelle ODIN, 286214
Mice, men, and differences therein
ISTH Academy, Alisa Wolberg, 286215
Professor Helge Stormorken, 1922‐2019
ISTH Academy, Faculty / Presenter(s), 286216
Corrigendum
ISTH Academy, Faculty / Presenter(s), 286217
Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
ISTH Academy, Suzanne Cannegieter, 286218
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH
ISTH Academy, Gary Moore, 286219
No resistance to activated protein C resistance—but choose wisely
ISTH Academy, Rita Selby, 286220
Response to Letter to the Editor submitted by Dr. Wada and Dr. Yamakawa re: Trauma‐induced coagulopathy: The past, present, and future
ISTH Academy, Faculty / Presenter(s), 286221
Sex matters: Practice 5P's when treating young women with venous thromboembolism
ISTH Academy, DARIO ZAZZARO, 286222
Trauma‐induced coagulopathy: The past, present, and future: A comment
ISTH Academy, Gregory Tesz, 286223
Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program
ISTH Academy, Gallia Levy, 286224
Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause
ISTH Academy, Johanna Gebhart, 286225
ISTH news and updates: Join the ISTH today
ISTH Academy, Faculty / Presenter(s), 286226
Response to Letter to the Editor submitted by Dr. Gando and Dr. Otomo re: Trauma‐induced coagulopathy: The past, present, and future
ISTH Academy, Naohito Inagaki, 286227
Termination of bleeding by a specific, anticatalytic antibody against plasmin
ISTH Academy, Maria Cristina Gottardi, 286228
What the Neighbors Say
ISTH Academy, Faculty / Presenter(s), 286229
Genomic momentum for hemostasis and thrombosis
ISTH Academy, Faculty / Presenter(s), 286230
Erratum
ISTH Academy, Faculty / Presenter(s), 286231
Issue Information
ISTH Academy, Faculty / Presenter(s), 286232
Cell surface expression of HLA I molecules as a marker of young platelets
ISTH Academy, Blandine Maître, 286233
Variability of von Willebrand factor‐related parameters in endothelial colony forming cells
ISTH Academy, Jeroen Eikenboom, 286234
Role of RXRβ in platelet function and arterial thrombosis
ISTH Academy, benjamin taisne, 286235
New insights into cytoskeletal remodeling during platelet production
ISTH Academy, Wolfgang Bergmeier, 286236
Trauma‐induced coagulopathy: The past, present, and future: A comment
ISTH Academy, Puja Soni, 286237
DIC in obstetrics: Diagnostic score, highlights in management, and international registry‐communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis
ISTH Academy, Maha Othman, 286238
New treatment paradigm for hemophilia poses challenges for legacy bioassays
ISTH Academy, Steven Pipe, 286239
Predicting the risk of recurrent venous thrombosis: What the future might bring
ISTH Academy, Suzanne Cannegieter, 286240
Pass interference: Getting in the way of platelets
ISTH Academy, Anirban Sen Gupta, 286241
The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis
ISTH Academy, Elisabetta Gualtieri, 286242
How We Treat Female Teens : patients with bleeding disorders & patients on anticoagulant therapies
ISTH Academy, Loren D’Angelo and Marilyn Blumenstein, 261693
Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon
ISTH Academy, Els Bailleul, 278059
Disseminated intravascular coagulation in cardiac arrest and resuscitation
ISTH Academy, Mattia Piredda, 278060
Emicizumab and thrombosis: The story so far
ISTH Academy, Michael Makris, 278061
Endogenous sex hormones and risk of venous thromboembolism in young women
ISTH Academy, Suzanne Cannegieter, 278062
Monitoring of blood coagulation with non‐contact drop oscillation rheometry
ISTH Academy, R. Glynn Holt, 278063
Thromboprophylaxis in pregnant women: For whom and which LMWH dosage? Reply
ISTH Academy, Claire Mclintock, 278064
Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH
ISTH Academy, Kathleen Freson, 278065
What the Neighbours Say
ISTH Academy, Faculty / Presenter(s), 278066
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Comment
ISTH Academy, Wolfgang Miesbach, 278067
Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application
ISTH Academy, Jonathan Douxfils, 278068
Endothelial force awakens a mechanism of portal hypertension: It's a neutrophil extracellular trap!
ISTH Academy, Jim Luyendyk, 278069
Thromboprophylaxis in pregnant women: For whom and which LMWH dosage?
ISTH Academy, Bernard Tardy, 278071
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism
ISTH Academy, Birgit Sm�brekke, 278072
Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population‐based cohort study
ISTH Academy, Anne Kristine Engebretsen, 278073
Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH
ISTH Academy, Simon Noble, 278074
Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues
ISTH Academy, Siamak Sabour, 278075
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply
ISTH Academy, Flora Peyvandi, 278076
Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding
ISTH Academy, Carsten Ley, 278077
Association of complete blood count parameters, d‐dimer, and soluble P‐selectin with risk of arterial thromboembolism in patients with cancer
ISTH Academy, Cihan Ay, 278078
Issue Information
ISTH Academy, Faculty / Presenter(s), 278079
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Faculty / Presenter(s), 278080
Toward standardization of assays measuring extracellular vesicle‐associated tissue factor activity
ISTH Academy, Johannes Thaler, 278081
Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issues
ISTH Academy, Rahat A. Abdoellakhan, 278082
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates
ISTH Academy, Francesco Bernardi, 278083
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta‐analysis
ISTH Academy, Cecilia Becattini, 278084
Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding
ISTH Academy, Mettine Bos, 278085
Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation
ISTH Academy, Toshiaki Iba, 278087
von Willebrand factor in experimental malaria‐associated acute respiratory distress syndrome
ISTH Academy, Simon F. De Meyer, 278088
Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
ISTH Academy, Stephan Glund, 278089

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings